company background image
DPH

Dechra Pharmaceuticals LSE:DPH Stock Report

Last Price

UK£34.94

Market Cap

UK£4.0b

7D

-3.7%

1Y

-30.1%

Updated

09 Aug, 2022

Data

Company Financials +
DPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance5/6
Financial Health5/6
Dividends3/6

DPH Stock Overview

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians.

Dechra Pharmaceuticals PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dechra Pharmaceuticals
Historical stock prices
Current Share PriceUK£34.94
52 Week HighUK£55.25
52 Week LowUK£30.66
Beta0.60
1 Month Change-6.83%
3 Month Change8.17%
1 Year Change-30.09%
3 Year Change20.32%
5 Year Change90.00%
Change since IPO2,546.97%

Recent News & Updates

Aug 02
Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Jun 10
These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Shareholder Returns

DPHGB PharmaceuticalsGB Market
7D-3.7%-0.7%0.8%
1Y-30.1%12.0%-6.4%

Return vs Industry: DPH underperformed the UK Pharmaceuticals industry which returned 12% over the past year.

Return vs Market: DPH underperformed the UK Market which returned -6.4% over the past year.

Price Volatility

Is DPH's price volatile compared to industry and market?
DPH volatility
DPH Average Weekly Movement5.2%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement5.4%
10% most volatile stocks in GB Market10.8%
10% least volatile stocks in GB Market2.7%

Stable Share Price: DPH is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: DPH's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19971,798Ian Pagehttps://www.dechra.com

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies.

Dechra Pharmaceuticals PLC Fundamentals Summary

How do Dechra Pharmaceuticals's earnings and revenue compare to its market cap?
DPH fundamental statistics
Market CapUK£3.97b
Earnings (TTM)UK£72.90m
Revenue (TTM)UK£640.60m

54.5x

P/E Ratio

6.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DPH income statement (TTM)
RevenueUK£640.60m
Cost of RevenueUK£276.70m
Gross ProfitUK£363.90m
Other ExpensesUK£291.00m
EarningsUK£72.90m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Sep 05, 2022

Earnings per share (EPS)0.64
Gross Margin56.81%
Net Profit Margin11.38%
Debt/Equity Ratio47.2%

How did DPH perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

61%

Payout Ratio